American Century Companies’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-34,173	Closed	-$532K	–	1391
2017 Q3	$532K	Buy	34,173 +1,933	+6%	+$30.1K	﹤0.01%	1223
2017 Q2	$452K	Sell	32,240 -2,646	-8%	-$37.1K	﹤0.01%	1244
2017 Q1	$767K	Buy	+34,886	New	+$767K	﹤0.01%	1171